Colorectal cancer

MONDAY, April 14 (HealthDay News)–A new combination of two medicines may prove helpful to restrain colorectal cancer and it has also been discovered that Sutent, which is a new powerful cancer medicine may slow down the development of liver cancer.

These are the results of two studies that were presented on Monday at the American Association for Cancer Research annual meeting in San Diego.

Difluoromethylornithine (DFMO)

According to the first report a treatment with two medicines, which were consisted of low doses of difluoromethylornithine (DFMO) in addition with sulindac, a non-steroidal anti-inflammatory drug (NSAID), decreased the risk of colorectal adenomas almost up to 95 percent.Colorectal adenomas are considered near the beginning indication of colon cancer.

“We, in fact, believe we are on track to make a medical resource to avoid colon cancer,”it was stated by Dr. Frank L. Meyskens, a professor of medicine at the University of California, Irving, and lead researcher of the study.

(more…)